Ethylene glycol diacetate
Strength: |
medium |
Threshold: |
0.093 ppm |
Common Name: |
Ethylene glycol diacetate |
IUPAC Name: |
2-acetyloxyethyl acetate |
Molecular Formula: |
C6H10O4 |
SMILES: |
CC(=O)OCCOC(=O)C |
Inchi: |
1S/C6H10O4/c1-5(7)9-3-4-10-6(2)8/h3-4H2,1-2H3 |
Inchi Key: |
JTXMVXSTHSMVQF-UHFFFAOYSA-N |
Cas No: |
111-55-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
146.14 |
Mass (g/mol) |
146.058 |
Molar Refractivity |
33.53 |
Net Charge |
|
HBD |
|
HBA |
4 |
Rt Bonds |
5 |
Rings |
|
TPSA |
52.60 |
Hetero Atoms |
4 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
-31.11 |
Boiling Point (°C@760.00mm Hg) |
187.00 to 193.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.2 |
Vapor Density (Air =1) |
5 |
Fraction Csp3 |
0.67 |
LogP |
0.113 |
iLOGP |
1.61 |
XLOGP3 |
0.01 |
WLOGP |
0.11 |
MLOGP |
0.25 |
ESOL Log S |
-0.42 |
ESOL Solubility (mg/ml) |
55.3 |
ESOL Solubility (mol/l) |
0.378 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-0.67 |
Ali Solubility (mg/ml) |
31.5 |
Ali Solubility (mol/l) |
0.22 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-0.82 |
Silicos-IT Solubility (mg/ml) |
22.1 |
Silicos-IT Solubility (mol/l) |
0.15 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-7.18 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.107 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
1 |
Acute Oral Toxicity |
1.442 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |